Kenmar Research Institute, LLC
Los Angeles, California 90057
0 studies enrolling now · 4 studies all time
What they study most
Adenocarcinoma, Carcinoma, Non-Small Cell Lung, Idiopathic Thrombocytopenic Purpura, Non-Small Cell Lung Cancer
Studies at this site
- A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer — Completed
- IGIV Study for Chronic ITP Patients Ages 3-70 — Completed
- A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
- CPG 7909 Injection in Non-Small Cell Lung Cancer — Completed